Bayer And janssen want doctors testimony stricken from record in xarlto trial
Drug Companies Want Doctor’s Testimony Stricken from Record in Xarelto Trial
August 15, 2017
Bayer and Janssen Pharmaceuticals have requested that the Louisiana federal judge presiding over the trial concerning controversial blood-thinning drug Xarelto strike from the record the testimony of a doctor who spoke on the subject of changing the drug’s labeling information.
The request comes in the early days of the third bellwether trial in the Multi-District Litigation (MDL) case against Bayer and Janssen (a subsidiary of Johnson & Johnson) over the allegedly dangerous side effects of Xarelto. The blood-thinner has been linked with cases of uncontrollable and sometimes fatal hemorrhaging.
At issue with the defendants’ request is a potential conflict: a doctor who spoke on behalf of the plaintiff gave contradictory testimony as to whether the U.S. Food and Drug Administration (FDA) had or had not struck from Xarelto’s label information about a blood clotting test. The defendants say that this contradiction makes Dr. Suzanne Parisian, a former officer with the FDA, ineligible to testify.
The plaintiff in the case is Dora Mingo, who developed deep vein thrombosis after a hip replacement surgery in 2015. Prescribed Xarelto, Mingo then suffered severe gastrointestinal bleeding; she alleges the drug’s makers knew of but concealed this potential health hazard.
The case is ongoing in Louisiana court.
If you’ve taken Xarelto, and have suffered from severe bleeding that you think may be connected with that drug, contact your doctor immediately. Then, contact the expert attorneys at TheLawFirm.com so we can help you put your lawsuit together.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!